How To Lower Irregular Heartbeat Risk?

According to some estimates, up to 9 percent of Americans will develop atrial fibrillation (AF) by the time they reach their 80s. AF is the most common heart arrhythmia (irregular heartbeat). Though it may cause no symptoms, it is often associated with palpitations, fainting and chest pain. It could eventually lead to stroke and heart failure.

AF might be treated with medications to either slow the heart rate to normal range (range control) or revert the heart rhythm back to normal (rhythm control). People with AF are often prescribed with blood-thinning drugs to prevent stroke.

A new study by researchers from the Harvard School of Public Health reported on January 26, 2012 in the journal ‘Circulation’ that older adults who had the highest blood levels of omega-3 fatty acids were 30 percent less likely to later develop an irregular heartbeat than those with the lowest blood levels of omega-3.

The omega-3 fatty acids measured in the study were eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). They can be found in oily fish and some enriched foods like eggs and in fish oil supplements.

While some previous studies have suggested that people who ate a lot of fish had a lower risk of developing AF, these studies relied on questionnaires answered by participants about how much fish they ate, which could only estimate the amount of omega-3s they consumed.

To get a more accurate measurement, the researchers sampled blood from 3,326 adults aged over 65. These participants’ health was tracked over the next 14 years (1992-2006) and 789 were found to develop AF.

Researchers’ analysis showed that those with the top 25 percent omega-3 levels in the bloodstreams at the beginning of the study were about 30 percent less likely to develop AF, comparing with those with the bottom 25 percent blood levels. Of the 3 omega-3 fatty acids, high DHA levels were linked to a 23 percent lower risk for AF, but no reduced risk was found for EPA and DPA.

Other heart experts not involved in the study cautioned that the study did not prove eating fish could lower AF risk. The study, however, did provide some idea that the fatty acids found in fish could work by stabilizing the excitability of heart muscle cells. Meanwhile, they also suggested further studies should be carried out to find out how fish oil might be used as a potential preventive measure against AF.

Can Heart Attack Damage Be Repaired?

Heart attack is a common name for myocardial infarction (MI) or acute myocardial infarction (AMI). When a person has a heart attack, some heart cells will die because of interruption of blood supply to a part of his or her heart. If a heart attack victim is not dealt with immediately, he or she might end up with death. That is why it is the leading cause for death for men and women worldwide.

Even if the victim is lucky enough to survive the heart attack, the damage to the heart muscle can never be repaired. He or she could have complications such as blood clots, heart failure, heart rupture, heart valve damage, irregular heartbeats and inflammation of the heart.

Good news is that doctors might be able to help the human heart repair itself in the near future. Researchers the Institute of Child Health in London had discovered cells in the hearts of mice that can make new muscle after a heart attack, and found a way to reactivate these cells that help build the heart in an embryo but generally go dormant in adulthood.

The findings, which were published on June 9, 2011 in the journal ‘Nature’, suggested that it might be possible to develop a drug for patients who are at risk of heart attack to keep those dormant cells ready in case of a heart attack.

In the study, researchers found that if the cells, which are found in the outer layer of the mouse heart, were injected with a particular substance and the animals were given a heart attack, the cells migrated to the injury part and made new muscle. The heart worked better as shown by several indicators found. Nevertheless, it was not clear if that was due to the new muscle or other known effects of the injected substance.

While it is generally agreed that very little in the cardiac world has translated from mice to man, some cardiac experts believe the new study would stir the field of heart regeneration studies that would eventually generate some positive findings to benefit people with heart disease.

What Would Heart Disease Cost United States 20 Years Later?

Most people are aware that heart disease is a chronic disease and the cost of treating it can never be cheap. When the condition of a heart disease patient is serious enough that it cannot no longer be treated by medication alone, he or she might need to undergo heart by-pass surgery or even heart transplant. Though advancement of technology has reduced the medical cost substantially, the amount of money that patients need to pay is still considered huge for most people.

Heart disease is the number one cause of death in most developed countries including United States, where one in 3 people has some form of heart disease. Every year, 17 percent of the cost of medical care, which is about US$273 billion, is meant for heart disease.

A study published on January 24, 2011 in ‘Circulation’, a journal of the American Heart Association (AHA) estimated that the cost of treating heart disease in United States are expected to triple to US$818 billion per year by 2030.

Based on the current disease rates, an expert panel of AHA expanded the cost according to projections from United States census data about approaching shifts in the population. The researchers also assumed that there would be no new discoveries made between now and 2030 to stop the tide of heart disease.

As revealed by the panel, 36.9 percent of Americans have some form of cardiovascular disease such as high blood pressure, coronary heart disease, heart failure or stroke presently. The number of people affected would increase to 116 million or 40.5 percent. Patients with stroke and heart failure are expected to increase the most by about 25 percent.

Most heart disease, according to AHA, is preventable if people can stick to healthy diet and adequate exercises. Unfortunately, many people do not seem to follow such advice. Meanwhile many heart disease patients do not take their medications as directed or drugs are not optimally prescribed to them. All these can further raise the cost of treatment.

Women Benefit More In Certain Heart Disease Treatment!

Heart failure is a condition in which heart is unable to pump blood at an adequate rate or in adequate volume. In serious cases, heart failure patients could lose their life with cessation of heartbeat.

There are numerous reasons why one might develop heart failure, which can be sudden or happen gradually over a periods of time. Some common causes are heart attack, high blood pressure, defective valves in the heart, cardiomyopathies (diseases of the heart muscle), too much alcohol, and congenital conditions that one is born with.

Besides taking right mix of medications, heart failure patients could have their condition reversed if the heart valve is repaired or fast heart rhythm is controlled. In some cases, certain devices are used to help the heart beat and contract properly. For example, cardiac resynchronization therapy with defibrillator (CRT-D), which is a form of therapy for congestive heart failure caused by dilated cardiomyopathy, have been found to have remarkable benefits on appropriately selected patients with heart failure.

CRT-D can help guard against sudden death from irregular heart rhythm by using a specialized pacemaker to re-coordinate the action of the right and left ventricles in patients with heart failure. It can also help strengthen pumping action in patients with heart damage.

Researchers from the University of Rochester pointed out in their findings that CRT-D works twice as well in women. Their study, which was published on February 7, 2011 in the ‘Journal of the American College of Cardiology’, found that when using CRT-D, there was a 70 percent reduction in heart failure in women compared a 35 percent drop in men.

This is probably the first time in history of heart disease research that has credited a certain type of treatment that is more effective in women than in men. In the past cardiac studies, men and women generally received similar benefit from preventive medical therapy.

According to researchers, CRT-D works better in women because women tend to suffer from a different type of heart disease than men. The male participants in the study were more likely to have coronary heart disease while the female participants were more likely to suffer from non-ischemic heart disease.

Coronary artery disease, which is also known as ischemic heart disease, is a condition in which narrowed vessels restrict blood flow to the heart. Non-ischemic heart disease, on the other hand, is one that involves more generalized scarring of heart tissue.

Let Garlic Help You Lower Hypertension!

While garlic is widely used as a seasoning or condiment, it has also been used as a remedy for infections, digestive disorders and fungal infections. In fact, traditional Indian Ayurvedic medicine practitioners have been using garlic to prevent high blood pressure for centuries. Meanwhile, many past studies also linked it to prevention of cancer and heart disease, and reduction of blood sugar.

A 12-week trial involving 50 patients that was conducted by Australian researchers from University of Adelaide reported that people with hypertension (high blood pressure) who took 4 capsules a day of a aged garlic extract had their systolic blood pressure reduced by around 10 mmHg, as compared with those who were given a placebo. The findings were published in October 2010 in the scientific journal ‘Maturitas’.

A placebo is a sham or simulated medical intervention that is commonly used in medical research. It is given as control treatments and can be inert tablets, sham surgery and other procedures based on false information.

However, the researchers pointed out that garlic, if it is taken in any other way, for instance, raw, fresh or in powdered form, does not have the same effect. When fresh garlic is cooked, its ingredient that is responsible for lowering blood pressure simply disappeared.

Though this was not the first study to examine the beneficial property of garlic, it was the first study to assess the impact of aged garlic extract that was evaluated as an additional treatment to other high blood pressure drugs, as claimed by the researchers.

Hypertension is a risk factor for coronary heart disease, stroke, heart failure, kidney failure, peripheral vascular disease and many other medical conditions. Globally, about 1 billion people have hypertension, which also affects about 1 in 3 adults in the United States. If hypertensive patients can have their blood pressure normalized, the risk of getting heart disease and stroke could be reduced.

Nevertheless, as garlic has blood-thinning effect and might interact with many drugs, it is advisable for patients to seek advice from qualified health practitioners or doctors before taking any garlic supplements.

Heart Failure Could Be Predicted By New Blood Test

Heart failure, also known as congestive heart failure, is a condition in which the heart is unable to supply sufficient blood flow to meet the need of the body. It is a common and potentially deadly condition. It affects about 6 to 10 percent of people aged 65 and above.

A number of tests that are commonly used by doctors to diagnose heart failure include ECG (Electrocardiogram), heart CT scan (computerized tomography), MRI (Magnetic resonance imaging) of the heart and cardiac stress tests. Routine blood test could help identify heart failure too.

Researchers from the University of Maryland, Baltimore, and the University of Texas, Dallas in the United States declared on November 15, 2010 in the ‘Journal of the American Medical Association’ (JAMA) that they have developed a new blood test to predict the risk of heart failure in older adults who do not have symptoms of heart disease.

The new test is a supposed to be more advance than that is currently used in emergency rooms to identify whether patients having chest pain is getting a heart attack or otherwise. Such findings might help assess the risk of death for older people aged above 65 who appear in good health. This group of people, which sees 80 percent of new congestive heart failure cases, is particularly difficult to gauge.

5,613 participants, who were all 65 years or older and free of heart failure at the outset, were involved in an ongoing study of cardiovascular health. The blood samples of 4,221 participants were studied and stored for up to 18 years. The marker was detected in two-thirds of the participants.

What the test does is to measure the level of troponin T that is a marker for the biological process of cell death leading to heart failure. The higher the level of troponin, the higher the risk that individual would have symptoms of heart failure or death from cardiovascular disease over the next 10 to 15 years.

While the meaning of these elevated levels was still unknown, the new test could detect troponin levels that are 10 times lower than the existing tests. The new test, however, is not commercially available in the United States yet.